Continuum Advisory’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.67K Buy
+93
New +$7.46K ﹤0.01% 1343
2025
Q2
Sell
-135
Closed -$8.6K 1032
2025
Q1
$8.6K Buy
+135
New +$8.46K ﹤0.01% 1015
2024
Q4
Sell
-224
Closed -$13.7K 1915
2024
Q3
$13.7K Buy
+224
New +$14.4K ﹤0.01% 921
2023
Q3
Sell
-4,622
Closed -$264K 466
2023
Q2
$264K Sell
4,622
-905
-16% -$51K 0.04% 386
2023
Q1
$304K Sell
5,527
-118
-2% -$6.34K 0.05% 350
2022
Q4
$283K Sell
5,645
-6,492
-53% -$317K 0.05% 351
2022
Q3
$529K Buy
12,137
+5,626
+86% +$273K 0.09% 226
2022
Q2
$314K Buy
+6,511
New +$316K 0.06% 327

Other funds holding JIRE

Continuum Advisory's JIRE Position: Q2 2026 in Review

Continuum Advisory opened a new position in JPMorgan International Research Enhanced Equity ETF (JIRE) in Q2 2026: 93 shares worth $7.67K. The stake represents ﹤0.01% of the portfolio and ranks #1343 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in JIRE as recently as Q1 2025.

Continuum Advisory first reported a position in JIRE in Q2 2022 and has held it in 8 quarters since. The position peaked at $529K in Q3 2022. 351 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Continuum Advisory held 93 shares of JPMorgan International Research Enhanced Equity ETF worth $7.67K as of Q2 2026.
  • JPMorgan International Research Enhanced Equity ETF was a new Continuum Advisory position in Q2 2026.
  • JPMorgan International Research Enhanced Equity ETF made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1343 holding.
  • Continuum Advisory first reported a position in JPMorgan International Research Enhanced Equity ETF in Q2 2022 and has held it in 8 quarters since.
  • Continuum Advisory's JPMorgan International Research Enhanced Equity ETF position peaked at $529K in Q3 2022.
  • 351 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.